Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
inositol 1,4,5-trisphosphate binding protein [RGD, Feb 2006].. Additionally we are shipping and PLCL1 Kits (1) and many more products for this protein.
Showing 10 out of 41 products:
PRIP interacts with the catalytic subunits of PP1 (show PPA1 Antibodies) and PP2A (show PPP2R4 Antibodies) and the interactions are regulated by phosphorylation. [review]
effect of DZP on PRIP-1 knockout mice was reduced
In postmenopausal women, our results suggest that the PLCL1 rs7595412 polymorphism has no obvious effect on hip bone size and bone mineral density but may be associated with increased proportion of vertebral fracture and increased levels of osteocalcin (show BGLAP Antibodies)
PRIP-1 plays an important role in type A receptor signaling for gamma-aminobutyric acid in the brain
PLCL1 is a novel gene associated with variation in hip bone size, which has a role in the pathogenesis of hip fractures
These results suggest that PRIPs are positively involved in the development of follicles via their regulation of LH-LHR (show LHCGR Antibodies) signaling and estradiol secretion.
Data show that PRIP (show NCOA6 Antibodies) is required for the fusion of Staphylococcus aureus-containing autophagosome-like vacuoles with lysosomes, indicating that PRIP (show NCOA6 Antibodies) is a novel modulator in the regulation of the innate immune system in non-phagocytic host cells.
PRIP (show NCOA6 Antibodies) promotes the translocation of phosphatases to lipid droplets to trigger the dephosphorylation of HSL (show LIPE Antibodies) and perilipin A (show PLIN1 Antibodies), thus reducing PKA-mediated lipolysis.
Suppressed expression of PRIP-1 induces an elevated expression of KCC2 (show SLC12A5 Antibodies) in the spinal cord, resulting in inhibition of nociception and amelioration of neuropathic pain in DKO mice.
PRIP (show NCOA6 Antibodies) is a novel LC3 (show MAP1LC3A Antibodies)-binding protein that acts as a negative modulator of autophagosome formation.
The results suggest that PRIP-1 (-/-) mice exhibit the changes of the function and subunits expression of GABA(A) receptor in the spinal cord, which may be responsible for abnormal pain sensation in these mice.
The results suggest that PRIP1 is involved in insulin (show INS Antibodies)-induced GABA(A) receptor insertion by recruiting active Akt (show AKT1 Antibodies) to the receptor complex.
PRIP-1 plays an important role in regulating the Ins (show INS Antibodies)(1,4,5)P3-mediated Ca2 (show CA2 Antibodies)+ signaling by modulating type1 inositol polyphosphate 5-phosphatase (show INPP5E Antibodies) activity through binding to Ins (show INS Antibodies)(1,4,5)P3.
PRIP (show NCOA6 Antibodies) plays an important role in BDNF (show BDNF Antibodies)-dependent regulation of GABA(A) receptors by mediating the specific association between beta subunits of these receptors with protein phosphatases
Plays an important role in controlling the dynamics of GABAA (show GABRg1 Antibodies) receptor phosphorylation through protein phosphatase 1 (show PPP1CB Antibodies) binding.
inositol 1,4,5-trisphosphate binding protein
, inactive phospholipase C-like protein 1
, phospholipase C related, but catalytically inactive protein
, phospholipase C, epsilon
, phospholipase C-deleted in lung carcinoma
, phospholipase C-related but catalytically inactive protein
, phospholipase C, eta 2 pseudogene
, 130kDa-Ins(1,4,5)P3 binding protein